Expression of Tim-3 Is Transiently Increased before Development of Anterior Chamber-Associated Immune Deviation

REFERENCES

• Wilbanks G A, Streilein J W. Distinctive humoral immune responses following anterior chamber and intravenous administration of soluble antigen. Evidence for active suppression of IgG2-secreting B lymphocytes. Immunology 1990; 71: 566–572, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Streilein J W. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 2003; 3: 879–889, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Fu T, Yang P Z, Huang X K, Huang Q, Zhou H Y, Li B, Zhong H H, Chen X. GATA-3 expression in the development of anterior chamber associated immune deviation. Chin Med J 2005; 118: 2000–2004, [INFOTRIEVE], [CSA]
   Google Scholar
• Kosiewicz M M, Alard P, Streilein J W. Alterations in cytokine production following intraocular injection of soluble protein antigen: impairment in IFN-γ and induction of TGF-β and IL-4 production. J Immunol 1998; 161: 5382–5390, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• γ 5Li X Y, D'orazio T J, Niederkorn J Y. Role of Th1 and Th2 cells in anterior chamber-associated immune deviation. Immunology 1996; 89: 34–40, [CROSSREF], [CSA]
   Google Scholar
• Nakamura T, Terajewiez A, Streilein J S. Mechanisms of peripheral tolerance following intracameral inoculation are independent of IL-13 or STAT6. J Immunol 2005; 175: 2643–2646, [INFOTRIEVE], [CSA]
   Google Scholar
• Mosmann T R, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138–146, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Abbas A K, Murphy K M, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787–793, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Matsuzaki S, Shinozaki K, Kobayashi N, Agematsu K. Polarization of Th1/Th2 in human CD4+ T cells separated by CD62L: analysis by transcription factors. Allergy 2005; 60: 780–787, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Lloyd C M, Delaney T, Nguyen T, Tian J, Martinez C -A, Coyle A J, Gutierrez-Ramos J C. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J Exp Med 2000; 191: 265–274, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Reddy M, Davis C, Wong J, Prabhakar U. Cutaneous lymphocyte antigen expression on activated lymphocytes and its association with IL-12R (beta1 and beta2), IL-2Ralpha, and CXCR3. Cell Immunol 2005; 236: 131–139, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Meyers J H, Sabatos C A, Chakravarti S, Kuchroo V K. The TIM gene family regulates autoimmune and allergic diseases. Trends Mol Med 2005; 11: 362–369, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• McIntire J J, Umetsu S E, Akbari O, Potter M, Kuchroo V K, Barsh G S, Freeman G J, Umetsu D T, DeKruyff R H. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immunol 2001; 2: 1109–1116, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Monney L, Sabatos C A, Gaglia J L, Ryu A, Waldner H, Chernova T, Manning S, Greenfield E A, Coyle A J, Sobel R A, Freeman G J, Kuchroo V K. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002; 415: 536–541, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Zhu C, Anderson A C, Schubart A, Xiong H, Imitola J, Khoury S J, Zheng X X, Strom T B, Kuchroo V K. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005; 6: 1245–1252, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Sanchez-Fueyo A, Tian J, Picarella D, Domenig C, Zheng X X, Sabatos C A, Manlongat N, Bender O, Kamradt T, Kuchroo V K, Gutierrez-Ramos J C, Coyle A J, Strom T B. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 2003; 4: 1093–1101, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Sabatos C A, Chakravarti S, Cha E, Schubart A, Sanchez-Fueyo A, Zheng X X, Coyle A J, Strom T B, Freeman G J, Kuchroo V K. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 2003; 4: 1102–1110, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Khademi M, Illes Z, Gielen A W, Marta M, Takazawa N, Baecher-Allan C, Brundin L, Hannerz J, Martin C, Harris R A, Hafler D A, Kuchroo V K, Olsson T, Piehl F, Wallstrom E. T cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J Immunol 2004; 172: 7169–7176, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Simmons W J, Koneru M, Mohindru M, Thomas R, Cutro S, Singh P, Dekruyff R H, Inghirami G, Coyle A J, Kim B S, Ponzio N M. Tim-3+ T-bet+ tumor-specific Th1 cells colocalize with and inhibit development and growth of murine neoplasms. J Immunol 2005; 174: 1405–1415, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gielen A W, Lobell A, Lidman O, Khademi M, Olsson T, Piehl F. Expression of T cell immunoglobulin- and mucin-domain-containing molecules-1 and -3 (TIM-1 and -3) in the rat nervous and immune systems. J Neuroimmunol 2005; 164: 93–104, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Chae S C, Song J H, Pounsambath P, Yuan H Y, Lee J H, Kim J J, Lee Y C, Chung H T. Molecular variations in Th1-specific cell surface gene Tim-3. Exp Mol Med 2004; 36: 274–278, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Chae S C, Park Y R, Shim S C, Yoon K S, Chung H T. The polymorphisms of Th1 cell surface gene Tim-3 are associated in a Korean population with rheumatoid arthritis. Immunol Lett 2004; 95: 91–95, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kuchroo V K, Umetsu D T, DeKruyff R H, Freeman G J. The TIM gene family: emerging roles in immunity and disease. Nat Rev Immunol 2003; 3: 454–462, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Mariat C, Sanchez-Fueyo A, Alexopoulos S P, Kenny J, Strom T B, Zheng X X. Regulation of T cell dependent immune responses by TIM family members. Philos Trans R Soc Lond B Biol Sci 2005; 360: 1681–1685, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Sakai R, Yamagami S, Inoki T, Tsuru T, Kawashima H. Th1/Th2-balance in anterior chamber-associated immune deviation by alloantigen. Graefe's Arch Clin Exp Ophthalmol 2002; 240: 154–159, [CSA]
   Google Scholar
• Griffith T S, Yu X, Herndon J M, Green D R, Ferguson T A. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 1996; 5: 7–16, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Wilbanks G A, Streilein J W. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J Immunol 1991; 146: 2610–2617, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Takahashi M, Ishimaru N, Yanagi K, Saegusa K, Haneji N, Shiota H, Hayashi Y. Requirement for splenic CD4+ T cells in the immune privilege of the anterior chamber of the eye. Clin Exp Immunol 1999; 116: 231–237, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Skelsey M E, Maybew E, Niederkorn J Y. CD25+, interleukin-10-producing CD4+ cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye. Immunology 2003; 110: 18–29, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Jiang H, Chess L. An integrated view of suppressor T cell subsets in immunoregulation. J Clin Invest 2004; 114: 1198–1208, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar